Friday, October 31, 2014
(Each presentation will include a 5 minute interactive discussion with audience)
| Time | Talk |
|---|---|
|
0715 |
Registration and continental breakfast with exhibitors |
|
0755 |
Welcome |
Prostate Cancer Screening and Diagnosis
|
|
|
0800 |
Where do we stand with PC screening in 2014? Dr. Girish Kulkarni |
|
0810 |
Lessons learned from the Prostate Lung Colorectal Ovarian (PLCO) Cancer Screening Trial Dr. Anthony Miller |
|
0830 |
The evolving role of MRI in PC diagnosis Dr. Robert Nam |
|
0840 |
MRI-based prostate biopsy techniques Dr. Laurent Milot |
|
0855 |
Optimization of prostate biopsy Dr. Samir Taneja |
Debate
|
|
|
0915 |
Pro Dr. Anthony Miller |
|
0925 |
Con Dr. Laurence Klotz |
|
0935- |
Rebuttal Dr. Anthony Miller |
|
0940- |
Rebuttal Dr. Laurence Klotz |
|
0945- |
Panel discussion with audience Drs. Kulkarni, Miller, Nam, Milot, Klotz, and Taneja |
|
10:00 |
Break with exhibitors |
Renal Cancer
|
|
|
1030 |
Re-thinking surgical risk – A new paradigm Dr. Robert Uzzo |
|
1050 |
Update on the management of small renal masses Dr. Tony Finelli |
|
1100 |
Partial nephrectomy for T1b/T2 RCC – How far should we go? Dr. Robert Uzzo |
|
1120 |
Approach to management of cystic renal masses: Is the Bosniak classification still useful? Dr. Samir Taneja |
|
1140- |
Cases and discussion Presented by Drs. Alex Zlotta and Michael Jewett Panel members Drs. Uzzo, Finelli, and Teneja |
|
1215 |
Lunch dessert served in exhibit area |
Testis Cancer
|
|
|
1300 |
Update on the management of Stage 1 NSGCT Dr. Joel Sheinfeld |
|
1325 |
Management of progression of Stage 1 disease on surveillance Dr. Rob Hamilton |
|
1335 |
Case presentations and discussion Drs. Sheinfeld, Hamilton, and Jewett |
Pediatric urology
|
|
|
1400 |
Transition and long-term outcomes of the augmented patient Dr. Mark Cain |
|
1430 |
Case and discussion Drs. Cain, Bagli, Farhat, and Lorenzo |
|
1500 |
Break with exhibitors |
Men’s Health and ED
|
|
|
1530 |
State-of-the-art management of post prostatectomy ED Dr. Arthur L. Burnett |
|
1600 |
5 things about PDE5 inhibitors you might not know Dr. S. Radomski |
|
1620 |
Treatment of ED in young men and recreational use of PDE5 inhibitors Dr. D. Elterman |
|
1640- |
Panel discussion and cases Drs. Burnett, Elterman, and Radomski |
| 1700 | Adjourn |
Saturday, November 1, 2014
(Each presentation will include a 5 minute interactive discussion with audience)
|
7:15 |
Registration and continental breakfast with exhibitors |
Prostate Cancer
|
|
|
0800 |
Vincent Colapinto Memorial Lecture – Longitudinal studies in PSA and prostate cancer Dr. H. Ballentine Carter |
|
0820 |
Discussion |
|
0830 |
Metformin, baldness, and prostate cancer Dr. Neil Fleshner |
|
0840 |
The Hopkins approach to active surveillance Dr. H. Ballentine Carter |
|
0850 |
Inflammation and prostate cancer revisited Dr. Alex Zlotta |
Pediatric urology
|
|
|
0900 |
A pediatric pot pourri Drs. Cain, Bagli, Farhat, and Lorenzo |
|
1000 |
Break with exhibitors |
Female stress incontinence
|
|
|
1030 |
Treatment specific evaluation of women with incontinence Dr. Lesley Carr |
|
1045 |
Are retropubic and transobturator midurethral slings the same? Dr. Ann Gormley |
|
1105 |
Current status of non-mesh SUI repairs Dr. J. Quentin Clemens |
|
1125 |
Benefits and problems with bulking agents Dr. S. Herschorn |
|
1140 |
Problem cases of SUI management Panel: Drs. Gormley, Quentin, and Carr |
|
1215 |
Lunch dessert served with exhibitors |
Functional urology
|
|
|
1300 |
Overview of AUA/SUFU OAB guidelines Dr. Ann Gormley |
|
1320 |
New drugs for OAB and nocturia Dr. S. Herschorn |
|
1340 |
Update on neuromodulation for OAB and retention Dr. J. Quentin Clemens |
|
1400 |
Discussion and cases Drs. Clemens, Gormley, and Herschorn |
Laparoscopy and MIS
|
|
|
1430 |
Historical perspectives of laparoscopic and robotic surgery Dr. J. Stuart Wolf, Jr. |
|
1500 |
Break |
Endourology
|
|
| 1530 | Optimizing flexible ureteroscopy in 2014:
The case for access sheaths Access sheaths are unnecessary Discussion |
| 1600 | Nephron sparing approach to TCC
Endoscopic management of upper tract TCC Alternatives to nephroureterectomy when endoscopy fails Discussion |
| 1630 | Optimizing PCNL in 2014: Who needs a nephrostomy?
Routine nephrostomy tube is unnecessary The case for the nephrostomy tube Discussion |
| 1700 | Adjourn |